Mediators of Inflammation / 2012 / Article / Fig 3

Clinical Study

Alterations in Monocyte CD16 in Association with Diabetes Complications

Figure 3

The effect of diabetes and its complications on percentage of CD16 monocytes. (A) Representative forward scatter and side scatter plots data from a control and diabetic subject showing the CD16+ cells (red dots) within the CD45+CD14+ monocyte population. (B) The percentage of CD16+ monocytes in control and diabetic subjects with and without complications. (C) The percentage of CD16+ monocytes in each monocyte subset grouped according to size and granularity. * different between groups.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.